Healthcare Sector Articles Healthcare Sector Articles - Page 2 June 11, 2026 10:25 AM ETPatent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionJeffrey Neal JohnsonNASDAQ:NUVLNYSE:GSKNYSE:PFERead Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 BillionJune 8, 2026 5:40 AM ET3 Longevity ETFs to Buy and Hold (and Hold)Nathan ReiffNYSEARCA:XBINYSEARCA:BMEDNASDAQ:AGNGRead 3 Longevity ETFs to Buy and Hold (and Hold)June 7, 2026 6:45 AM ET3 ETFs For the Coming Genomics RevolutionNathan ReiffBATS:ARKGBATS:HELXNYSEARCA:IDNARead 3 ETFs For the Coming Genomics RevolutionJune 4, 2026 11:10 AM ETMedtronic Bottoms, Healthy Rebound AheadThomas HughesNYSE:MDTNASDAQ:MMEDRead Medtronic Bottoms, Healthy Rebound AheadJune 2, 2026 9:15 AM ETEli Lilly Wins Back CVS Health, Reverting Novo's AdvantageLeo MillerNYSE:LLYNYSE:NVONYSE:CVSRead Eli Lilly Wins Back CVS Health, Reverting Novo's AdvantageJune 1, 2026 12:20 PM ETWhy These Three Big Buybacks Are Sending Very Different Signals to InvestorsLeo MillerNYSE:RBLXNYSE:PWRNYSE:BSXRead Why These Three Big Buybacks Are Sending Very Different Signals to InvestorsMay 31, 2026 5:45 AM ET5 Best Growth Stocks for the Next 10 YearsChris MarkochNYSE:TSMNASDAQ:AVGONYSE:NVORead 5 Best Growth Stocks for the Next 10 YearsMay 28, 2026 9:00 AM ETIs Co-Diagnostics National Security’s Next Diagnostic Pick?Jeffrey Neal JohnsonNASDAQ:OSURNASDAQ:CODXNASDAQ:GOVXRead Is Co-Diagnostics National Security’s Next Diagnostic Pick?May 28, 2026 7:15 AM ETHims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?Jessica MitacekNYSE:HIMSNYSE:NVONYSE:LLYRead Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?May 24, 2026 6:50 AM ETAmylyx Stock: Why the Full Pipeline Story MattersChris MarkochNASDAQ:AMLXNASDAQ:REGNNYSE:MRKRead Amylyx Stock: Why the Full Pipeline Story MattersMay 23, 2026 5:50 AM ETKiniksa Pharmaceuticals Still Has Room to Run After 100% RallyChris MarkochNASDAQ:KNSARead Kiniksa Pharmaceuticals Still Has Room to Run After 100% RallyMay 21, 2026 9:40 AM ETThe Silver Lining of Last Week's Hims & Hers Earnings MissJessica MitacekNYSE:HIMSNYSE:NVORead The Silver Lining of Last Week's Hims & Hers Earnings MissMay 20, 2026 12:55 PM ETFrom Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookLeo MillerNYSE:LLYNYSE:NVORead From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookMay 18, 2026 6:55 AM ETThese Stocks Could Be the Biggest Winners of the 2026 MidtermsChris MarkochNYSE:LMTNYSE:RTXNYSEARCA:XLVRead These Stocks Could Be the Biggest Winners of the 2026 Midterms Page 2 of 2 ‹ Most Recent12 More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsReal Estate SectorSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
